Dr. Tsai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1000
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2013 - 2015
University of North Carolina HospitalsResidency, Internal Medicine, 2010 - 2013
The Warren Alpert Medical School of Brown UniversityClass of 2010
Certifications & Licensure
CA State Medical License 2013 - 2026
NC State Medical License 2010 - 2013
Clinical Trials
- Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors Start of enrollment: 2020 Jun 16
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- For the Long Haul: Management of Long-Term Survivors after Melanoma Systemic Therapy.Jordyn Silverstein, Neha Goyal, Katy K Tsai
Current Oncology Reports. 2024-07-01 - Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations.Alexandra M Haugh, Robert C Osorio, Rony A Francois, Michael E Tawil, Katy K Tsai
Cancers. 2024-03-29 - 1 citationsPOLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients withV600-mutant melanoma with brain metastasis.Alexander M Menzies, Georgina V Long, Amiee Kohn, Hussein Tawbi, Jeffrey Weber
Neuro-Oncology Advances. 2024-03-18
Press Mentions
UCSF Health Cancer Experts Featured at Premier Cancer MeetingJune 4th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
